Ellie Eunkyung Im

Insider Reports History

Location: Waltham, MA
Signature: /s/ Barbara Bispham, as attorney-in-fact for Ellie Im
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ellie Eunkyung Im:

Form 4 holding Chief Medical Officer

CRESCENT BIOPHARMA, INC.

Security class: Ordinary Shares
Shares / value: 21,298
Estimated value: $321,173
Report date: 15 Dec 2025
Price: $15.08
Ownership: Direct

Form 4 holding Chief Medical Officer

CRESCENT BIOPHARMA, INC.

Security class: Stock Option (Right to Buy)
Shares / value: 65,190
Estimated value
Report date: 15 Dec 2025
Price
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount

Insider Reports Filed by Ellie Eunkyung Im

4 GLYC

CRESCENT BIOPHARMA, INC.

Report period: 15 Dec 2025
Transactions: 3
Transaction value: $0
Filing time: 17 Dec 2025, 16:41
Role: Chief Medical Officer
Next action: Open filing details

3 GLYC

CRESCENT BIOPHARMA, INC.

Report period: 13 Jun 2025
Transactions: 0
Transaction value: $0
Filing time: 30 Jun 2025, 16:21
Role: Chief Medical Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .